Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Language
Publication year range
1.
Asian Pac J Cancer Prev ; 19(9): 2359-2371, 2018 Sep 26.
Article in English | MEDLINE | ID: mdl-30255688

ABSTRACT

Background: Human papillomavirus (HPV) infection is associated with cervical cancer; however, it is controversial whether it is involved in non-cervical genital cancers. Objective: This study aimed to evaluate articles on the prevalence of HPV in penile cancer, vulvar cancer, colorectal cancer, prostate cancer and anal canal cancer in studies conducted in Brazil. Methods: The study was conducted in accordance with the Preferred Reporting of Systematic Reviews and Meta-Analysis Statement. Comprehensive searches for HPV and cancer for the years 2006 to 2016 were conducted in two databases (PubMed and Web of Knowledge) and Google Scholar system. We also tracked the references of all eligible articles to identify additional non-captured publications through online surveys. Results: Eighteen studies, with a combined sample size of 1,552 patients were analyzed. The overall prevalence of HPV was 43% (95% CI: 36­51%; p < 0.001). The pooled prevalence of HPV in penile cancer was 42% (95% CI: 32­55%; p < 0.001), in colorectal cancer it was 67% (95% CI: 64­70%; p < 0.001) and in vulvar cancer 43% (95% CI: 34­55%; p < 0.001). HPV 16 was the most prevalent in all sites evaluated, with prevalence estimated at 54% (95% CI: 44­66%; p < 0.001), followed by genotypes 33 (21%; 95% CI: 17­28; p < 0.001), 6 (15%; 95% CI: 8­26%; p < 0.001), 11 (13%; 95% CI: 5­32%; p < 0.001) and 18 (12%; 95% CI: 7­22%; p < 0.001), respectively. The pooled prevalence of single infection was 82% and infection by multiple genotypes of HPV was 22%. Conclusion: Our study demonstrated a high prevalence of HPV in non-cervical genital cancers in Brazil, with predominance of genotype 16, providing evidence for the need for preventive and control measures to avoid future harm to the population.


Subject(s)
Genitalia/virology , Papillomaviridae/pathogenicity , Papillomavirus Infections/complications , Urogenital Neoplasms/etiology , Urogenital Neoplasms/virology , Uterine Cervical Neoplasms/etiology , Uterine Cervical Neoplasms/virology , Brazil , Female , Humans , Prevalence
2.
Neurosci Lett ; 495(1): 63-6, 2011 May 09.
Article in English | MEDLINE | ID: mdl-21421022

ABSTRACT

The ß-adrenergic blocker and 5-HT(1A) receptor antagonist pindolol has been combined with selective serotonin reuptake inhibitors (SSRIs) in patients with depressive and anxiety disorders to shorten the onset of the clinical action and/or increase the proportion of responders. The results of a previous study have shown that pindolol potentiates the panicolytic effect of paroxetine in rats submitted to the elevated T-maze (ETM). Since reported evidence has implicated the 5-HT(1A) receptors of the dorsal periaqueductal gray matter (DPAG) in the panicolytic effect of antidepressants, rats treated with pindolol (5.0mg/kg, i.p.) and paroxetine (1.5mg/kg, i.p.) received a previous intra-DPAG injection of the selective 5-HT(1A) antagonist, WAY-100635 (0.4 µg) and were submitted to the ETM. Pretreatment with WAY-100635 reversed the increase in escape latency, a panicolytic effect, determined by the pindolol-paroxetine combination. These results implicate the 5-HT(1A) receptors of the DPAG in the panicolytic effect of the pindolol-paroxetine combination administered systemically. They also give further preclinical support for the use of this drug combination in the treatment of panic disorder.


Subject(s)
Adrenergic beta-Antagonists/pharmacology , Maze Learning/drug effects , Panic/drug effects , Paroxetine/pharmacology , Periaqueductal Gray/metabolism , Pindolol/pharmacology , Receptor, Serotonin, 5-HT1A/metabolism , Selective Serotonin Reuptake Inhibitors/pharmacology , Animals , Drug Synergism , Escape Reaction/drug effects , Male , Piperazines/pharmacology , Pyridines/pharmacology , Rats , Rats, Wistar , Reaction Time , Serotonin 5-HT1 Receptor Antagonists/pharmacology
3.
J Ethnopharmacol ; 115(1): 131-9, 2008 Jan 04.
Article in English | MEDLINE | ID: mdl-17997061

ABSTRACT

Kielmeyera coriacea Mart. (Clusiaceae), known as "Pau Santo" or "Saco de Boi" in the central Brazilian plateau region, is used to treat several tropical diseases. The present study evaluated the toxic effects of dichloromethane (DcM) extract of Kielmeyera coriacea stems, administered to rodents. In the acute toxicity tests, mice receiving doses of this extract by the oral and intraperitoneal routes, showed reversible effects, with LD50 values of 1503.0 and 538.8 mg/kg, respectively. In the repeated-dose oral (90 days) toxicity tests, male and female Wistar rats were treated by gavage with different doses of DcM extract (5, 25 or 125 mg/kg). In biochemical and haematological evaluations, the results varied widely in respect to dose and sex, with no linear profile, and did not show clinical correlations. In the histopathological examinations, the groups exhibited some changes, but there were no significant differences between the groups compared to the controls. In conclusion, these investigations appeared to indicate the safety of acute and repeated oral administration of the DcM extract of Kielmeyera coriacea stems, which can therefore be continuously used with safety.


Subject(s)
Clusiaceae/chemistry , Plant Extracts/toxicity , Administration, Oral , Animals , Brazil , Dose-Response Relationship, Drug , Drug Administration Schedule , Female , Injections, Intraperitoneal , Lethal Dose 50 , Male , Medicine, Traditional , Methylene Chloride/chemistry , Mice , Plant Extracts/administration & dosage , Plant Stems , Rats , Rats, Wistar , Sex Factors , Toxicity Tests, Acute
4.
Braz. arch. biol. technol ; 48(2): 211-216, Mar. 2005. graf
Article in English | LILACS | ID: lil-398032

ABSTRACT

A atividade antiulcerogênica do extrato hidroetanólico de caule de Kielmeyera coriacea Mart. (Guttiferae) foi avaliada em ratos por meio de três modelos experimentais: etanol-ácido, indometacina e estresse agudo. O índice ulcerativo observado após o tratamento com o extrato de Kielmeyera coriacea foi comparado com a droga de referência, cimetidina. O tratamento com o extrato mostrou significante atividade anti-ulcerogênica nos modelos de indução de lesões de mucosa gástrica produzidas por etanol-ácido e indometacina, mas não contra úlcera induzida pelo modelo de estresse agudo. Etanol-ácido e agentes antiinflamatórios, como a indometacina, são compostos que produzem úlcera de mucosa gástrica. Os resultados deste estudo sugerem uma atividade protetora de mucosa gástrica para o extrato de Kielmeyera coriacea.

5.
Acta sci., Health sci ; 26(2): 365-368, jul.-dez. 2004. tab, graf
Article in English | LILACS | ID: lil-413752

ABSTRACT

O objetivo deste estudo foi investigar as propriedades psicotrópicas do extrato hidroetanólico liofilizado obtido de caule de Kielmeyera coriacea após tratamento agudo ou crônico por via oral (gavagem) em ratos. As atividades ansiolítica, antidepressiva e estimulante de sistema nervoso central, foram avaliadas através da utilização dos testes do labirinto em cruz elevado (LCE), nado forçado (NF) e campo-aberto (TCA), respectivamente. A administração crônica de EH de caule de Kielmeyera coriacea (60.0 mg/kg) produziu redução no tempo de imobilidade no teste do NF, comparável a mipramina (20.0 mg/kg), sem aumentar a atividade locomotora no TCA. A dose de 120.0 mg/kg do mesmo extrato aumentou significativamente a percentagem de entradas nos braços abertos no teste do LCE após administração aguda. Estes resultados mostram que EH de caule de Kielmeyera coriacea apresenta perfil de composto ansiolítico e ntidepressivo


Subject(s)
Humans , Anti-Anxiety Agents/analysis , Antidepressive Agents , Clusiaceae/toxicity , Plant Extracts , Psychotropic Drugs/analysis , Psychotropic Drugs/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...